Lobby wrap: New pharma registrations for drug approvals, rare drug policy

As part of a number of new drug-related lobbying registrations this past week, Akcea Therapeutics of Cambridge Mass. signed Carl Baltare of Global Public Affairs to lobby about the drug approval process and policies on drugs for rare diseases, along with patented medicine pricing. Stephen Sampson from Global Public Affairs had registered for Akcea in […]

The post Lobby wrap: New pharma registrations for drug approvals, rare drug policy appeared first on iPolitics.

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

Akcea [+]    Global Public Affairs [+]    Sampson [+]   

More #news: